
Like many other pension sector player, Danish Industriens Pension wants to dramatically expand its holdings of real estate assets to serve as a stable counterweight to fluctuating equities and bonds still carrying low yields.
The most recent manifestation of this strategy emerged on June 29 with the pension company buying the coming headquarters of domestic biotech firm Genmab in Copenhagen for a price of DKK 620m (EUR 83.28m).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app